Global Crude Heparin Competitive Landscape Professional Research Report 2025
Research Summary
Crude heparin refers to a raw, unprocessed form of the anticoagulant drug heparin derived from animal tissues, typically the intestines and lungs of pigs or cattle. It is a complex mixture of sulfated glycosaminoglycans, consisting of chains of repeating sugar units. Crude heparin undergoes extraction and purification processes to remove impurities and separate it into different fractions based on its molecular weight and activity. Heparin is widely used in medicine to prevent blood clotting during surgical procedures, dialysis, and certain medical conditions like deep vein thrombosis. The refinement of crude heparin is crucial to ensure its safety and efficacy, as improper purification can lead to contamination and adverse effects. As a result, stringent quality control measures are in place during the production and processing of heparin to meet pharmaceutical standards.
According to DIResearch's in-depth investigation and research, the global Crude Heparin market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Crude Heparin include Bioiberica, Shenzhen Hepalink, Sanofi, Nanjing King-friend, Fengrun Biological Technology, Aspen Oss, Hebei Changshan Biochemical, Changzhou Qianhong, Hepac (Darling Ingredients), Huaian MDC Pharmaceutical, Yantai Dongcheng Biochemicals etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Crude Heparin. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Crude Heparin market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Crude Heparin market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Crude Heparin industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Crude Heparin Include:
Bioiberica
Shenzhen Hepalink
Sanofi
Nanjing King-friend
Fengrun Biological Technology
Aspen Oss
Hebei Changshan Biochemical
Changzhou Qianhong
Hepac (Darling Ingredients)
Huaian MDC Pharmaceutical
Yantai Dongcheng Biochemicals
Crude Heparin Product Segment Include:
Pig Intestine Mucosa Heparin
Bovine Heparin and Others
Crude Heparin Product Application Include:
UFH
LMWH
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Crude Heparin Industry PESTEL Analysis
Chapter 3: Global Crude Heparin Industry Porter’s Five Forces Analysis
Chapter 4: Global Crude Heparin Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Crude Heparin Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Crude Heparin Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Crude Heparin Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Crude Heparin Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Crude Heparin Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Crude Heparin Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Crude Heparin Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Crude Heparin Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 Crude Heparin Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Crude Heparin Product by Type
- 1.2.1 Pig Intestine Mucosa Heparin
- 1.2.2 Bovine Heparin and Others
- 1.3 Crude Heparin Product by Application
- 1.3.1 UFH
- 1.3.2 LMWH
- 1.4 Global Crude Heparin Market Revenue and Sales Analysis
- 1.4.1 Global Crude Heparin Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Crude Heparin Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Crude Heparin Market Sales Price Trend Analysis (2020-2032)
- 1.5 Crude Heparin Industry Trends and Innovation
- 1.5.1 Crude Heparin Industry Trends and Innovation
- 1.5.2 Crude Heparin Market Drivers and Challenges
- 2 Crude Heparin Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Crude Heparin Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Crude Heparin Market Analysis by Regions
- 4.1 Crude Heparin Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Crude Heparin Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Crude Heparin Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Crude Heparin Revenue and Market Share Forecast by Region (2026-2032)
- 4.3 Global Crude Heparin Sales and Forecast Analysis (2020-2032)
- 4.3.1 Global Crude Heparin Sales and Market Share by Region (2020-2025)
- 4.3.2 Global Crude Heparin Sales Forecast by Region (2026-2032)
- 4.4 Global Crude Heparin Sales Price Trend Analysis (2020-2032)
- 5 Global Crude Heparin Market Size by Type and Application
- 5.1 Global Crude Heparin Market Size by Type
- 5.1.1 Global Crude Heparin Revenue and Forecast Analysis by Type (2020-2032)
- 5.1.2 Global Crude Heparin Sales and Forecast Analysis by Type (2020-2032)
- 5.2 Global Crude Heparin Market Size by Application
- 5.2.1 Global Crude Heparin Revenue and Forecast Analysis by Application (2020-2032)
- 5.2.2 Global Crude Heparin Sales and Forecast Analysis by Application (2020-2032)
- 6 North America
- 6.1 North America Crude Heparin Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Crude Heparin Market Size by Type
- 6.3.1 North America Crude Heparin Sales by Type (2020-2032)
- 6.3.2 North America Crude Heparin Revenue by Type (2020-2032)
- 6.4 North America Crude Heparin Market Size by Application
- 6.4.1 North America Crude Heparin Sales by Application (2020-2032)
- 6.4.2 North America Crude Heparin Revenue by Application (2020-2032)
- 6.5 North America Crude Heparin Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Crude Heparin Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Crude Heparin Market Size by Type
- 7.3.1 Europe Crude Heparin Sales by Type (2020-2032)
- 7.3.2 Europe Crude Heparin Revenue by Type (2020-2032)
- 7.4 Europe Crude Heparin Market Size by Application
- 7.4.1 Europe Crude Heparin Sales by Application (2020-2032)
- 7.4.2 Europe Crude Heparin Revenue by Application (2020-2032)
- 7.5 Europe Crude Heparin Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Crude Heparin Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Crude Heparin Market Size by Type
- 8.3.1 China Crude Heparin Sales by Type (2020-2032)
- 8.3.2 China Crude Heparin Revenue by Type (2020-2032)
- 8.4 China Crude Heparin Market Size by Application
- 8.4.1 China Crude Heparin Sales by Application (2020-2032)
- 8.4.2 China Crude Heparin Revenue by Application (2020-2032)
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Crude Heparin Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Crude Heparin Market Size by Type
- 9.3.1 APAC (excl. China) Crude Heparin Sales by Type (2020-2032)
- 9.3.2 APAC (excl. China) Crude Heparin Revenue by Type (2020-2032)
- 9.4 APAC (excl. China) Crude Heparin Market Size by Application
- 9.4.1 APAC (excl. China) Crude Heparin Sales by Application (2020-2032)
- 9.4.2 APAC (excl. China) Crude Heparin Revenue by Application (2020-2032)
- 9.5 APAC (excl. China) Crude Heparin Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Crude Heparin Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Crude Heparin Market Size by Type
- 10.3.1 Latin America Crude Heparin Sales by Type (2020-2032)
- 10.3.2 Latin America Crude Heparin Revenue by Type (2020-2032)
- 10.4 Latin America Crude Heparin Market Size by Application
- 10.4.1 Latin America Crude Heparin Sales by Application (2020-2032)
- 10.4.2 Latin America Crude Heparin Revenue by Application (2020-2032)
- 10.5 Latin America Crude Heparin Market Size by Country
- 10.6 Latin America Crude Heparin Market Size by Country
- 10.6.1 Mexico
- 10.6.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Crude Heparin Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Crude Heparin Market Size by Type
- 11.3.1 Middle East & Africa Crude Heparin Sales by Type (2020-2032)
- 11.3.2 Middle East & Africa Crude Heparin Revenue by Type (2020-2032)
- 11.4 Middle East & Africa Crude Heparin Market Size by Application
- 11.4.1 Middle East & Africa Crude Heparin Sales by Application (2020-2032)
- 11.4.2 Middle East & Africa Crude Heparin Revenue by Application (2020-2032)
- 11.5 Middle East Crude Heparin Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Crude Heparin Market Sales, Revenue and Price by Key Manufacturers (2021-2025)
- 12.1.1 Global Crude Heparin Market Sales by Key Manufacturers (2021-2025)
- 12.1.2 Global Crude Heparin Market Revenue by Key Manufacturers (2021-2025)
- 12.1.3 Global Crude Heparin Average Sales Price by Manufacturers (2021-2025)
- 12.2 Crude Heparin Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Crude Heparin Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Bioiberica
- 13.1.1 Bioiberica Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Bioiberica Crude Heparin Product Portfolio
- 13.1.3 Bioiberica Crude Heparin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.2 Shenzhen Hepalink
- 13.2.1 Shenzhen Hepalink Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Shenzhen Hepalink Crude Heparin Product Portfolio
- 13.2.3 Shenzhen Hepalink Crude Heparin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.3 Sanofi
- 13.3.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Sanofi Crude Heparin Product Portfolio
- 13.3.3 Sanofi Crude Heparin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.4 Nanjing King-friend
- 13.4.1 Nanjing King-friend Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Nanjing King-friend Crude Heparin Product Portfolio
- 13.4.3 Nanjing King-friend Crude Heparin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.5 Fengrun Biological Technology
- 13.5.1 Fengrun Biological Technology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Fengrun Biological Technology Crude Heparin Product Portfolio
- 13.5.3 Fengrun Biological Technology Crude Heparin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.6 Aspen Oss
- 13.6.1 Aspen Oss Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Aspen Oss Crude Heparin Product Portfolio
- 13.6.3 Aspen Oss Crude Heparin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.7 Hebei Changshan Biochemical
- 13.7.1 Hebei Changshan Biochemical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Hebei Changshan Biochemical Crude Heparin Product Portfolio
- 13.7.3 Hebei Changshan Biochemical Crude Heparin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.8 Changzhou Qianhong
- 13.8.1 Changzhou Qianhong Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Changzhou Qianhong Crude Heparin Product Portfolio
- 13.8.3 Changzhou Qianhong Crude Heparin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.9 Hepac (Darling Ingredients)
- 13.9.1 Hepac (Darling Ingredients) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Hepac (Darling Ingredients) Crude Heparin Product Portfolio
- 13.9.3 Hepac (Darling Ingredients) Crude Heparin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.10 Huaian MDC Pharmaceutical
- 13.10.1 Huaian MDC Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Huaian MDC Pharmaceutical Crude Heparin Product Portfolio
- 13.10.3 Huaian MDC Pharmaceutical Crude Heparin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.11 Yantai Dongcheng Biochemicals
- 13.11.1 Yantai Dongcheng Biochemicals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Yantai Dongcheng Biochemicals Crude Heparin Product Portfolio
- 13.11.3 Yantai Dongcheng Biochemicals Crude Heparin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Crude Heparin Industry Chain Analysis
- 14.2 Crude Heparin Industry Raw Material and Suppliers Analysis
- 14.2.1 Crude Heparin Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Crude Heparin Typical Downstream Customers
- 14.4 Crude Heparin Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook